<DOC>
	<DOC>NCT00051909</DOC>
	<brief_summary>Study of an investigational medication for the treatment of Alzheimer's Disease in patients who are not taking Aricept, Reminyl, Exelon.</brief_summary>
	<brief_title>Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Must have a clinical diagnosis of Alzheimer's Disease Must be at least 50 years of age Must fluently read and speak English Must have a reliable caregiver Has serious health problems other than Alzheimer's Disease Cannot swallow whole pills Has had a menstrual period in the last two years Takes insulin for diabetes Has taken Aricept, Reminyl, or Exelon in the last 5 weeks</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Alzheimer's Disease</keyword>
</DOC>